Moody’s rates Acadia revolver, loan Ba2

Moody's Investors Service said it assigned Ba2 ratings to Acadia Healthcare Co., Inc.'s new $500 million revolving credit facility expiring in 2021 and $400 million term loan A due in 2021.

Proceeds from the new term loan and Acadia's previously announced divestiture of facilities in the United Kingdom were applied to the repayment of the company's previous term loan and revolver.

Acadia's remaining existing ratings, including the B1 corporate family rating and B1-PD probability of default rating, are unchanged.

The outlook remains stable.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.